Archive - Where Tech Meets Bio

Weekly Tech+Bio Highlights #52: Open AI's Accelerated Cell Reprogramming

Tempus-Paige Digital Pathology Acquisition Deal, Reasoning AIs for Biology & Antibiotics

Aug 26 •

and

Digital Pathology: Slides, AI, & Challenges

Pathology has progressed from glass slides to AI-driven digital diagnostics, promising to transform disease detection, while facing adoption and market…

Aug 14 •

and

Weekly Tech+Bio Highlights #51: Neurosymbolic AI for Biomedical Research

$6B AI Drug Discovery Deal & FDA’s AI Lifecycle Concept for Health Care

Aug 11 •

and

Building the Virtual Cell: AI Foundation Models and Billion-Cell Datasets

From early 2000s and a 2012 milestone to a decade-long quiet—virtual cell modeling is resurging with transformers, perturbation atlases, and…

Aug 7 •

and

Weekly Tech+Bio Highlights #50: How Robust Are Pathology Foundation Models?

CRISPR-GPT, Current Gene Delivery Landscape, & Thought-Controlled iPad

Aug 5 •

and

July 2025

H1 2025 Recap: Key Signals from the Tech+Bio Frontier

A high-signal summary of some of the most important moves and trends shaping biotech and tech-enabled life sciences in the first half of 2025

Jul 31 •

Weekly Tech+Bio Highlights #49: Radiology AI Grows, Impact Evidence Lags

~$1.8B in new funds and rounds; Can AI Scientists Help Rare Disease Research? & Key Tension in Applying Virtual Cell Models to Drug Development

Jul 28 •

and

Weekly Tech+Bio Highlights #48: Bi-Weekly Overview

AI Protein Design Models, Policy Changes & Industry Funding for Q2

Jul 23 •

and

How Organoids and AI Are Replacing Animal Testing

As FDA & NIH formalize support for non-animal testing, organ-on-a-chip, organoids, and ML-based toxicity models are being integrated into preclinical…

Jul 18 •

and

Can AI Diagnose Better Than Humans?

With Microsoft’s agentic AI orchestrator solving NEJM cases at 85% accuracy, we profile 22+ companies advancing diagnostic AI across imaging, genomics…

Jul 11 •

and

Weekly Tech+Bio Highlights #47: Microsoft AI's Diagnostic Multi-Agent Orchestrator

Also: New Foundation Model for Zero-Shot Antibody Design & The Role of AI in Rare Disease Tech

Jul 7 •

and

Emerging Brain-Computer Interface Industry Across Chips, AI, and Regulation

From surgically embedded chips, adaptive neuroheadsets, and AI-steered interfaces to an intensifying geopolitical contest

Jul 4 •

and

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts